My cart
In the shopping cart is not goods, to choose and buy!
  • Product Name
  • Size
  • Quantity
  • Amount
    Selected items : 0 pieces Total : CHECK OUT()
    Catalog No: V1573
    CAS No. (CAS Registry Number): 755038-02-9
    Description: BI2536 (BI-2536; BI 2536) is a novel PLK1/BRD4 dual inhibitor with potential antitumor activity. It inhibits PLK1/BRD4 with IC50s of 0.83 and 25 nM, respectively in a cell-...
    Catalog No: V1574
    CAS No. (CAS Registry Number): 755038-65-4
    Description: Volasertib (formerly also known as BI6727, BI-6727, BI 6727) is a novel and highly potent dihydropteridinone-based Plk1 (polo-like kinase 1) inhibitor with potential antineoplastic activi...
    Catalog No: V1575
    CAS No. (CAS Registry Number): 1225497-78-8
    Description: Rigosertib sodium (formerly known as ON-01910; ON01910; Estybon), the sodium salt of Rigosertib, is a novel, potent and non-ATP-competitive inhibitor of PLK1 with potential anticance...
    Catalog No: V1576
    CAS No. (CAS Registry Number): 929095-18-1
    Description: GSK-461364 (GSK461364; GSK 461364) is a novel, potent, selective, reversible and ATP-competitive small molecule Polo-like kinase 1 (PLK1) inhibitor with potential...
    Catalog No: V1577
    CAS No. (CAS Registry Number): 173529-46-9
    Description: HMN-214 (HMN 214; HMN214), stilbene derivative, is a potent and orally bioactive prodrug of HMN-176, which alters the cellular spatial orientation of Plk1 (polo-like kinase-1). ...
    Catalog No: V1578
    CAS No. (CAS Registry Number): 1228960-69-7
    Description: MLN0905 (MLN-0905; MLN 0905) is a novel, potent and selective small-molecule inhibitor of polo-like kinase-1 (PLK1) with potential antineoplastic activity. It inhibits PLK1 with an IC50 o...
    10页次1/2首页<12>尾页
    Products are for research use only;  We do not sell to patients
    Tel: 1-708-310-1919
    Fax: 1-708-557-7486
    Subscribe to our E-newsletter
    • Name*
    • *
    • E-mail*
    • *
    • instructions:
    • *
    Copyright 2020 InvivoChem LLC | All Rights Reserved